Arcellx (ACLX) Financials

$66.51 +0.34 (+0.51%)

As of 04:00 PM Eastern

Annual Income Statements for Arcellx

This table shows Arcellx's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-65	-189	-71	-107
Consolidated Net Income / (Loss)	-65	-189	-71	-107
Net Income / (Loss) Continuing Operations	-65	-189	-71	-107
Total Pre-Tax Income	-65	-189	-70	-105
Total Operating Income	-65	-191	-90	-138
Total Gross Profit	0.00	0.00	110	108
Total Revenue	0.00	0.00	110	108
Operating Revenue	-	0.00	110	108
Total Cost of Revenue	0.00	0.00	0.00	0.00
Total Operating Expenses	65	191	200	246
Selling, General & Admin Expense	18	42	66	88
Research & Development Expense	47	150	134	157
Total Other Income / (Expense), net	0.05	2.58	20	32
Interest & Investment Income	-	4.30	24	33
Other Income / (Expense), net	0.05	-1.72	-3.84	-1.03
Income Tax Expense	-	0.00	0.66	2.07
Basic Earnings per Share	($145.55)	($5.19)	($1.47)	($2.00)
Weighted Average Basic Shares Outstanding	446.38K	36.36M	48.06M	53.57M
Diluted Earnings per Share	($145.55)	($5.19)	($1.47)	($2.00)
Weighted Average Diluted Shares Outstanding	446.38K	36.36M	48.06M	53.57M
Weighted Average Basic & Diluted Shares Outstanding	-	47.84M	52.80M	54.94M

This table shows Arcellx's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-93	-39	-27	-24	-39	20	-7.20	-27	-26	-47	-62
Consolidated Net Income / (Loss)	-93	-39	-27	-24	-39	20	-7.20	-27	-26	-47	-62
Net Income / (Loss) Continuing Operations	-93	-39	-27	-24	-39	20	-7.20	-27	-26	-47	-62
Total Pre-Tax Income	-93	-39	-27	-24	-39	20	-7.20	-27	-26	-46	-62
Total Operating Income	-94	-40	-30	-30	-45	15	-16	-35	-34	-53	-69
Total Gross Profit	0.00	-	18	14	15	63	39	27	26	15	8.13
Total Revenue	0.00	-	18	14	15	63	39	27	26	15	8.13
Operating Revenue	0.00	-	18	14	15	63	39	27	26	15	8.13
Total Cost of Revenue	0.00	-	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00
Total Operating Expenses	94	40	48	44	60	48	55	62	60	68	77
Selling, General & Admin Expense	10	14	15	16	16	19	23	21	20	24	26
Research & Development Expense	83	26	33	28	44	29	32	41	39	45	51
Total Other Income / (Expense), net	1.00	1.01	3.44	5.42	5.52	5.47	8.61	8.13	7.97	7.58	6.63
Interest & Investment Income	-	-	-	-	-	-	-	-	-	-	6.64
Other Income / (Expense), net	1.00	-3.29	3.44	5.42	5.52	-18	8.61	8.13	7.97	-26	-0.01
Income Tax Expense	0.00	-	0.33	-0.28	-0.01	0.62	0.00	0.34	0.22	1.51	0.00
Basic Earnings per Share	($2.12)	($0.98)	($0.58)	($0.50)	($0.81)	$0.42	($0.14)	($0.51)	($0.48)	($0.87)	($1.13)
Weighted Average Basic Shares Outstanding	43.82M	36.36M	46.77M	48.11M	48.35M	48.06M	52.76M	53.52M	53.82M	53.57M	55.26M
Diluted Earnings per Share	($2.12)	($0.98)	($0.58)	($0.50)	($0.81)	$0.42	($0.14)	($0.51)	($0.48)	($0.87)	($1.13)
Weighted Average Diluted Shares Outstanding	43.82M	36.36M	46.77M	48.11M	48.35M	48.06M	52.76M	53.52M	53.82M	53.57M	55.26M
Weighted Average Basic & Diluted Shares Outstanding	43.85M	47.84M	47.99M	48.36M	48.69M	52.80M	53.50M	53.76M	54.07M	54.94M	55.11M

This table details how cash moves in and out of Arcellx's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-16	36	332	-291
Net Cash From Operating Activities	-54	-99	208	-83
Net Cash From Continuing Operating Activities	-54	-99	208	-83
Net Income / (Loss) Continuing Operations	-65	-189	-71	-107
Consolidated Net Income / (Loss)	-65	-189	-71	-107
Depreciation Expense	1.04	1.32	2.04	5.19
Amortization Expense	0.21	-2.13	-11	-15
Non-Cash Adjustments To Reconcile Net Income	6.76	89	75	61
Changes in Operating Assets and Liabilities, net	2.72	1.33	212	-27
Net Cash From Investing Activities	-80	-118	-155	-183
Net Cash From Continuing Investing Activities	-80	-118	-155	-183
Purchase of Property, Plant & Equipment	-5.78	-2.28	-21	-13
Purchase of Investments	-74	-274	-442	-597
Sale and/or Maturity of Investments	0.00	158	309	428
Net Cash From Financing Activities	118	253	279	-24
Net Cash From Continuing Financing Activities	118	253	279	-24
Issuance of Common Equity	0.00	260	301	1.16
Other Financing Activities, net	0.05	-7.21	-22	-25
Cash Income Taxes Paid	-	0.00	0.21	1.64

This table details how cash moves in and out of Arcellx's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Change in Cash & Equivalents	-108	7.42	211	29	-175	268	-242	-55	62	-56	-25
Net Cash From Operating Activities	-17	-28	182	-23	-10	58	-32	-36	31	-46	-63
Net Cash From Continuing Operating Activities	-17	-28	182	-23	-10	58	-32	-36	31	-46	-63
Net Income / (Loss) Continuing Operations	-93	-39	-27	-24	-39	20	-7.20	-27	-26	-47	-62
Consolidated Net Income / (Loss)	-93	-39	-27	-24	-39	20	-7.20	-27	-26	-47	-62
Depreciation Expense	0.34	0.42	0.43	0.44	0.45	0.72	0.83	1.24	1.33	1.79	1.58
Amortization Expense	-0.81	-1.36	-1.98	-2.71	-2.42	-3.94	-4.36	-4.13	-3.40	-3.57	-3.14
Non-Cash Adjustments To Reconcile Net Income	70	7.75	-8.05	11	29	43	17	15	15	15	23
Changes in Operating Assets and Liabilities, net	6.43	4.66	219	-7.78	1.81	-1.04	-38	-21	44	-12	-23
Net Cash From Investing Activities	-81	34	-67	51	-160	21	-207	-7.87	36	-4.12	38
Net Cash From Continuing Investing Activities	-81	34	-67	51	-160	21	-207	-7.87	36	-4.12	38
Purchase of Property, Plant & Equipment	-0.39	-1.28	-0.98	-7.23	-7.93	-5.29	-6.43	-3.21	-2.29	-1.50	-0.78
Purchase of Investments	-129	-26	-162	-	-238	-42	-318	-83	-60	-136	-79
Sale and/or Maturity of Investments	48	61	96	59	86	69	118	78	98	134	117
Net Cash From Financing Activities	-9.71	1.31	95	0.12	-4.99	189	-2.99	-10	-4.66	-6.02	0.54
Net Cash From Continuing Financing Activities	-9.71	1.31	95	0.12	-4.99	189	-2.99	-10	-4.66	-6.02	0.54
Other Financing Activities, net	-8.89	1.31	-4.56	-0.41	-4.46	-12	-2.99	-11	-4.66	-6.54	0.54

This table presents Arcellx's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	129	314	825	711
Total Current Assets	113	267	716	599
Cash & Equivalents	31	64	395	106
Restricted Cash	-	0.00	1.90	0.21
Short-Term Investments	74	191	307	482
Prepaid Expenses	8.19	12	12	12
Plant, Property, & Equipment, net	10	11	43	46
Total Noncurrent Assets	5.66	36	66	66
Long-Term Investments	-	0.00	27	38
Other Noncurrent Operating Assets	5.66	36	39	27
Total Liabilities & Shareholders' Equity	129	314	825	711
Total Liabilities	17	109	340	257
Total Current Liabilities	15	57	118	125
Accounts Payable	1.33	9.05	2.62	2.10
Accrued Expenses	13	12	18	57
Current Deferred Revenue	0.18	0.00	0.00	0.00
Other Current Liabilities	0.15	36	97	67
Total Noncurrent Liabilities	2.07	52	222	131
Noncurrent Deferred Revenue	1.90	0.00	0.00	0.00
Other Noncurrent Operating Liabilities	0.18	52	222	131
Commitments & Contingencies	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	233	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-122	205	485	455
Total Preferred & Common Equity	-122	205	485	455
Preferred Stock	0.00	0.00	0.00	0.00
Total Common Equity	-122	205	485	455
Common Stock	8.62	524	874	951
Retained Earnings	-130	-319	-389	-497
Accumulated Other Comprehensive Income / (Loss)	-0.02	-0.22	0.55	0.85

This table presents Arcellx's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025
Total Assets	337	623	624	614	780	734	765	648
Total Current Assets	290	571	558	491	589	530	587	554
Cash & Equivalents	57	275	304	126	155	100	162	81
Restricted Cash	-	-	-	-	0.21	0.21	0.21	0.21
Short-Term Investments	224	259	203	314	419	417	412	462
Accounts Receivable	-	21	29	31	0.00	0.00	0.00	0.00
Prepaid Expenses	9.52	17	22	20	15	13	13	11
Plant, Property, & Equipment, net	10	14	22	38	45	46	47	46
Total Noncurrent Assets	37	37	43	85	146	158	129	48
Long-Term Investments	-	-	-	43	117	130	102	22
Other Noncurrent Operating Assets	37	37	43	42	29	28	26	26
Total Liabilities & Shareholders' Equity	337	623	624	614	780	734	765	648
Total Liabilities	101	319	330	348	283	247	282	231
Total Current Liabilities	45	166	156	173	108	88	137	112
Accounts Payable	2.96	4.53	5.69	7.19	3.10	4.87	5.99	4.37
Accrued Expenses	11	14	12	17	34	42	43	43
Current Deferred Revenue	0.00	107	94	94	31	15	70	57
Other Current Liabilities	31	40	44	55	40	26	18	7.36
Total Noncurrent Liabilities	56	153	174	175	175	159	145	119
Noncurrent Deferred Revenue	0.00	106	124	121	112	96	83	69
Other Noncurrent Operating Liabilities	29	47	49	54	63	63	62	49
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	236	304	294	266	497	487	483	417
Total Preferred & Common Equity	236	304	294	266	497	487	483	417
Total Common Equity	236	304	294	266	497	487	483	417
Common Stock	516	650	664	676	894	912	931	975
Retained Earnings	-280	-346	-370	-409	-397	-424	-450	-559
Accumulated Other Comprehensive Income / (Loss)	-0.40	0.09	-0.01	-0.07	-0.51	-0.79	1.90	0.65

This table displays calculated financial ratios and metrics derived from Arcellx's official financial filings.

Metric	2021	2022	2023	2024
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-
Revenue Growth	0.00%	0.00%	0.00%	-2.16%
EBITDA Growth	0.00%	-204.13%	46.99%	-44.92%
EBIT Growth	0.00%	-197.03%	51.43%	-47.89%
NOPAT Growth	0.00%	-194.16%	53.01%	-53.06%
Net Income Growth	0.00%	-190.41%	62.53%	-51.86%
EPS Growth	0.00%	96.43%	71.68%	-36.05%
Operating Cash Flow Growth	0.00%	-83.09%	309.03%	-140.21%
Free Cash Flow Firm Growth	0.00%	0.00%	273.17%	-228.61%
Invested Capital Growth	0.00%	-788.30%	-392.59%	30.38%
Revenue Q/Q Growth	0.00%	0.00%	133.87%	-30.73%
EBITDA Q/Q Growth	0.00%	-14.17%	25.52%	-99.44%
EBIT Q/Q Growth	0.00%	-13.28%	28.57%	-120.24%
NOPAT Q/Q Growth	0.00%	-11.23%	37.96%	-98.17%
Net Income Q/Q Growth	0.00%	-10.76%	45.42%	-165.56%
EPS Q/Q Growth	0.00%	88.51%	48.78%	-181.69%
Operating Cash Flow Q/Q Growth	0.00%	-6.40%	70.41%	-501.07%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	36.06%	-144.41%
Invested Capital Q/Q Growth	0.00%	-185.97%	-13.47%	12.36%
Profitability Metrics	-	-	-	-
Gross Margin	0.00%	0.00%	100.00%	100.00%
EBITDA Margin	0.00%	0.00%	-93.12%	-137.93%
Operating Margin	0.00%	0.00%	-81.47%	-127.46%
EBIT Margin	0.00%	0.00%	-84.96%	-128.41%
Profit (Net Income) Margin	0.00%	0.00%	-64.08%	-99.46%
Tax Burden Percent	100.00%	100.00%	100.95%	101.97%
Interest Burden Percent	100.00%	97.77%	74.72%	75.96%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	-58.08%	-119.11%	-20.48%	-22.84%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	0.00%	0.00%	-16.46%	-18.04%
Return on Assets (ROA)	0.00%	0.00%	-12.41%	-13.97%
Return on Common Equity (ROCE)	63.09%	-31.37%	-20.48%	-22.84%
Return on Equity Simple (ROE_SIMPLE)	53.47%	-92.06%	-14.56%	-23.60%
Net Operating Profit after Tax (NOPAT)	-46	-134	-63	-96
NOPAT Margin	0.00%	0.00%	-57.03%	-89.22%
Net Nonoperating Expense Percent (NNEP)	-18.60%	-30.49%	-1.58%	-1.63%
Return On Investment Capital (ROIC_SIMPLE)	-	-65.32%	-12.96%	-21.17%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	0.00%	0.00%	60.14%	81.91%
R&D to Revenue	0.00%	0.00%	121.33%	145.54%
Operating Expenses to Revenue	0.00%	0.00%	181.47%	227.46%
Earnings before Interest and Taxes (EBIT)	-65	-193	-94	-139
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-64	-194	-103	-149
Valuation Ratios	-	-	-	-
Price to Book Value (P/BV)	0.00	6.63	5.57	9.12
Price to Tangible Book Value (P/TBV)	0.00	6.63	5.57	9.12
Price to Revenue (P/Rev)	0.00	0.00	24.49	38.42
Price to Earnings (P/E)	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	34.84	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	17.87	32.62
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	9.50	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	14.83	0.00
Leverage & Solvency	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00
Financial Leverage	-0.94	-1.13	-1.43	-1.44
Leverage Ratio	1.15	1.40	1.65	1.63
Compound Leverage Factor	1.15	1.37	1.23	1.24
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	208.63%	0.00%	0.00%	0.00%
Common Equity to Total Capital	-108.63%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00
Altman Z-Score	2.22	4.84	4.74	9.03
Noncontrolling Interest Sharing Ratio	208.63%	73.66%	0.00%	0.00%
Liquidity Ratios	-	-	-	-
Current Ratio	7.60	4.71	6.06	4.78
Quick Ratio	7.05	4.50	5.94	4.68
Cash Flow Metrics	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-77	133	-171
Operating Cash Flow to CapEx	-937.89%	-4,361.13%	968.70%	-621.31%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-
Asset Turnover	0.00	0.00	0.19	0.14
Accounts Receivable Turnover	0.00	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	4.09	2.42
Accounts Payable Turnover	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	0.00	0.00	0.00	0.00
Capital & Investment Metrics	-	-	-	-
Invested Capital	7.25	-50	-246	-171
Invested Capital Turnover	0.00	0.00	-0.75	-0.52
Increase / (Decrease) in Invested Capital	0.00	-57	-196	75
Enterprise Value (EV)	253	1,104	1,971	3,521
Market Capitalization	124	1,359	2,702	4,147
Book Value per Share	($272.22)	$4.67	$9.97	$8.41
Tangible Book Value per Share	($272.22)	$4.67	$9.97	$8.41
Total Capital	112	205	485	455
Total Debt	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00
Net Debt	-105	-255	-731	-626
Capital Expenditures (CapEx)	5.78	2.28	21	13
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-6.65	-45	-106	-114
Debt-free Net Working Capital (DFNWC)	98	210	598	474
Net Working Capital (NWC)	98	210	598	474
Net Nonoperating Expense (NNE)	19	55	7.77	11
Net Nonoperating Obligations (NNO)	-105	-255	-731	-626
Total Depreciation and Amortization (D&A)	1.25	-0.80	-9.01	-10
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	0.00%	-95.90%	-105.32%
Debt-free Net Working Capital to Revenue	0.00%	0.00%	542.18%	439.06%
Net Working Capital to Revenue	0.00%	0.00%	542.18%	439.06%
Earnings Adjustments	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	($5.19)	($1.47)	($2.00)
Adjusted Weighted Average Basic Shares Outstanding	0.00	36.36M	48.06M	53.57M
Adjusted Diluted Earnings per Share	$0.00	($5.19)	($1.47)	($2.00)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	36.36M	48.06M	53.57M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	47.84M	52.80M	54.94M
Normalized Net Operating Profit after Tax (NOPAT)	-46	-134	-63	-96
Normalized NOPAT Margin	0.00%	0.00%	-57.03%	-89.22%
Pre Tax Income Margin	0.00%	0.00%	-63.48%	-97.54%
Debt Service Ratios	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-1.06%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Arcellx's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	119.16%	91.47%	74.03%	-75.83%	-79.29%
EBITDA Growth	-456.32%	-119.09%	-11.27%	13.54%	55.74%	85.42%	62.42%	-12.65%	32.91%	-1,150.61%	-253.55%
EBIT Growth	-443.41%	-109.44%	-3.74%	21.57%	57.64%	92.54%	73.36%	-11.29%	34.82%	-2,343.42%	-320.23%
NOPAT Growth	-448.66%	-93.27%	-16.73%	5.53%	52.21%	151.94%	48.09%	-18.38%	25.07%	-355.83%	-335.79%
Net Income Growth	-443.41%	-88.64%	-5.00%	22.48%	57.65%	150.89%	73.68%	-14.04%	34.24%	-337.26%	-765.10%
EPS Growth	93.89%	97.61%	53.60%	40.48%	61.79%	142.86%	75.86%	-2.00%	40.74%	-307.14%	-707.14%
Operating Cash Flow Growth	-36.20%	-27.73%	658.65%	-0.30%	39.32%	311.66%	-117.53%	-60.29%	404.09%	-179.02%	-97.90%
Free Cash Flow Firm Growth	0.00%	0.00%	739.54%	641.72%	447.43%	622.28%	-120.52%	-137.10%	-126.76%	-153.17%	-103.89%
Invested Capital Growth	0.00%	-788.30%	-1,451.73%	-1,379.49%	-1,141.46%	-392.59%	15.32%	24.88%	9.86%	30.38%	23.71%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	-20.15%	4.58%	322.20%	-37.83%	-30.24%	-4.94%	-41.35%	-46.75%
EBITDA Q/Q Growth	-205.61%	52.61%	31.43%	7.54%	-56.43%	84.38%	-66.36%	-177.20%	6.84%	-191.11%	12.65%
EBIT Q/Q Growth	-201.81%	53.39%	33.64%	10.66%	-63.00%	91.79%	-122.92%	-273.17%	4.53%	-207.67%	12.66%
NOPAT Q/Q Growth	-200.02%	57.39%	23.86%	2.95%	-51.77%	146.31%	-176.07%	-121.33%	3.94%	-58.12%	-29.62%
Net Income Q/Q Growth	-201.81%	58.02%	29.87%	12.76%	-64.90%	150.45%	-136.27%	-277.91%	4.91%	-82.01%	-32.26%
EPS Q/Q Growth	-152.38%	53.77%	40.82%	13.79%	-62.00%	151.85%	-133.33%	-264.29%	5.88%	-81.25%	-29.89%
Operating Cash Flow Q/Q Growth	26.16%	-65.30%	761.49%	-112.42%	55.33%	676.60%	-154.78%	-13.61%	184.74%	-249.84%	-37.18%
Free Cash Flow Firm Q/Q Growth	-25.26%	160.34%	674.44%	-7.45%	-19.67%	25.44%	-122.00%	-67.33%	42.06%	-149.23%	15.62%
Invested Capital Q/Q Growth	-204.87%	-185.97%	-360.85%	7.42%	-1.75%	-13.47%	20.78%	17.88%	-22.11%	12.36%	13.19%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	0.00%	0.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
EBITDA Margin	0.00%	0.00%	-159.45%	-184.65%	-276.19%	-10.22%	-27.34%	-108.64%	-106.47%	-528.48%	-866.90%
Operating Margin	0.00%	0.00%	-170.04%	-206.68%	-299.94%	23.75%	-40.27%	-127.79%	-129.14%	-348.17%	-847.56%
EBIT Margin	0.00%	0.00%	-150.82%	-168.76%	-263.03%	-5.11%	-18.34%	-98.09%	-98.52%	-516.82%	-847.71%
Profit (Net Income) Margin	0.00%	0.00%	-152.66%	-166.79%	-262.99%	31.42%	-18.34%	-99.34%	-99.37%	-308.40%	-766.02%
Tax Burden Percent	100.00%	100.00%	101.22%	98.83%	99.98%	96.96%	100.00%	101.27%	100.87%	103.30%	100.00%
Interest Burden Percent	100.00%	90.07%	100.00%	100.00%	100.00%	-633.82%	100.00%	100.00%	100.00%	57.77%	90.36%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	3.04%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	-72.10%	-119.11%	-71.47%	-59.31%	-51.56%	-20.48%	-12.63%	-13.80%	-10.79%	-22.84%	-35.56%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	0.00%	0.00%	-6.21%	-10.89%	-26.08%	-0.99%	-3.44%	-20.91%	-22.26%	-72.61%	-91.21%
Return on Assets (ROA)	0.00%	0.00%	-6.29%	-10.77%	-26.07%	6.09%	-3.44%	-21.18%	-22.46%	-43.33%	-82.42%
Return on Common Equity (ROCE)	-72.10%	-31.37%	-71.47%	-59.31%	-51.56%	-20.48%	-12.63%	-13.80%	-10.79%	-22.84%	-35.56%
Return on Equity Simple (ROE_SIMPLE)	-72.10%	0.00%	-62.55%	-62.34%	-48.67%	0.00%	-10.18%	-11.06%	-8.37%	0.00%	-38.96%
Net Operating Profit after Tax (NOPAT)	-66	-28	-21	-21	-31	15	-11	-24	-24	-37	-48
NOPAT Margin	0.00%	0.00%	-119.03%	-144.68%	-209.96%	23.03%	-28.19%	-89.45%	-90.40%	-243.72%	-593.29%
Net Nonoperating Expense Percent (NNEP)	-21.41%	-6.11%	-1.62%	-0.78%	-2.15%	1.08%	0.63%	-0.47%	-0.40%	-1.46%	-2.23%
Return On Investment Capital (ROIC_SIMPLE)	-	-13.66%	-	-	-	3.00%	-	-	-	-8.18%	-11.57%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	0.00%	0.00%	86.18%	108.62%	107.05%	30.67%	57.95%	78.24%	78.65%	155.70%	322.62%
R&D to Revenue	0.00%	0.00%	183.85%	198.06%	292.89%	45.58%	82.33%	149.55%	150.49%	292.47%	624.94%
Operating Expenses to Revenue	0.00%	0.00%	270.04%	306.68%	399.94%	76.25%	140.27%	227.79%	229.14%	448.17%	947.56%
Earnings before Interest and Taxes (EBIT)	-93	-43	-27	-24	-39	-3.23	-7.20	-27	-26	-79	-69
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-93	-44	-29	-26	-41	-6.45	-11	-30	-28	-81	-70
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.48	6.63	4.85	5.17	6.52	5.57	6.82	6.06	9.29	9.12	8.65
Price to Tangible Book Value (P/TBV)	3.48	6.63	4.85	5.17	6.52	5.57	6.82	6.06	9.29	9.12	8.65
Price to Revenue (P/Rev)	0.00	0.00	82.29	47.11	36.78	24.49	25.72	20.40	28.81	38.42	46.93
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	52.50	31.39	26.55	17.87	20.47	15.93	24.47	32.62	39.56
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	8.15	8.77	10.28	9.50	0.00	0.00	183.18	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	8.55	10.79	12.82	14.83	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-1.07	-1.13	-1.40	-1.32	-1.47	-1.43	-1.53	-1.48	-1.55	-1.44	-1.38
Leverage Ratio	1.43	1.40	1.64	1.62	1.89	1.65	1.75	1.74	1.84	1.63	1.56
Compound Leverage Factor	1.43	1.26	1.64	1.62	1.89	-10.46	1.75	1.74	1.84	0.94	1.41
Debt to Total Capital	10.27%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	10.27%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	89.73%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	-0.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	1.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	-0.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	-0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	2.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	-0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	3.69	6.41	2.66	2.63	2.55	5.10	7.34	7.16	9.53	9.31	8.73
Noncontrolling Interest Sharing Ratio	0.00%	73.66%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	6.48	4.71	3.44	3.57	2.84	6.06	5.46	6.01	4.29	4.78	4.93
Quick Ratio	6.27	4.50	3.34	3.43	2.72	5.94	5.32	5.85	4.19	4.68	4.83
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-48	29	226	209	168	210	-46	-77	-45	-112	-94
Operating Cash Flow to CapEx	-4,324.42%	-2,156.74%	18,575.71%	-312.88%	-127.44%	1,100.47%	-496.07%	-1,128.20%	1,341.44%	-3,070.71%	-8,095.51%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.00	0.04	0.06	0.10	0.19	0.19	0.21	0.23	0.14	0.11
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	1.48	2.02	1.97	4.09	4.44	4.22	3.65	2.42	1.70
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	-17	-50	-230	-213	-217	-246	-195	-160	-195	-171	-149
Invested Capital Turnover	0.00	0.00	-0.17	-0.33	-0.40	-0.75	-0.62	-0.78	-0.76	-0.52	-0.45
Increase / (Decrease) in Invested Capital	-17	-57	-247	-229	-199	-196	35	53	21	75	46
Enterprise Value (EV)	569	1,104	940	1,011	1,252	1,971	2,695	2,306	3,812	3,521	3,039
Market Capitalization	822	1,359	1,474	1,518	1,735	2,702	3,386	2,953	4,489	4,147	3,604
Book Value per Share	$5.39	$4.67	$6.35	$6.12	$5.50	$9.97	$9.41	$9.11	$8.99	$8.41	$7.59
Tangible Book Value per Share	$5.39	$4.67	$6.35	$6.12	$5.50	$9.97	$9.41	$9.11	$8.99	$8.41	$7.59
Total Capital	263	205	304	294	266	485	497	487	483	455	417
Total Debt	27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-254	-255	-534	-506	-483	-731	-691	-647	-677	-626	-565
Capital Expenditures (CapEx)	0.39	1.28	0.98	7.23	7.93	5.29	6.43	3.21	2.29	1.50	0.78
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-35	-45	-128	-105	-121	-106	-93	-75	-124	-114	-102
Debt-free Net Working Capital (DFNWC)	246	210	405	402	318	598	481	442	450	474	442
Net Working Capital (NWC)	246	210	405	402	318	598	481	442	450	474	442
Net Nonoperating Expense (NNE)	27	11	6.02	3.16	7.93	-5.30	-3.87	2.71	2.34	9.87	14
Net Nonoperating Obligations (NNO)	-254	-255	-534	-506	-483	-731	-691	-647	-678	-626	-565
Total Depreciation and Amortization (D&A)	-0.47	-0.94	-1.55	-2.27	-1.97	-3.22	-3.53	-2.89	-2.07	-1.78	-1.56
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	0.00%	-716.18%	-324.48%	-257.38%	-95.90%	-70.86%	-51.80%	-79.69%	-105.32%	-132.51%
Debt-free Net Working Capital to Revenue	0.00%	0.00%	2,262.78%	1,247.77%	674.79%	542.18%	365.20%	305.30%	288.98%	439.06%	575.05%
Net Working Capital to Revenue	0.00%	0.00%	2,262.78%	1,247.77%	674.79%	542.18%	365.20%	305.30%	288.98%	439.06%	575.05%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($2.12)	($0.98)	$0.00	($0.50)	($0.81)	$0.42	($0.14)	($0.51)	($0.48)	($0.87)	($1.13)
Adjusted Weighted Average Basic Shares Outstanding	43.82M	36.36M	0.00	48.11M	48.44M	48.06M	52.76M	53.52M	53.82M	53.57M	55.26M
Adjusted Diluted Earnings per Share	($2.12)	($0.98)	$0.00	($0.50)	($0.81)	$0.42	($0.14)	($0.51)	($0.48)	($0.87)	($1.13)
Adjusted Weighted Average Diluted Shares Outstanding	43.82M	36.36M	0.00	48.11M	48.44M	48.06M	52.76M	53.52M	53.82M	53.57M	55.26M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	43.85M	47.84M	0.00	48.36M	48.69M	52.80M	53.50M	53.76M	54.07M	54.94M	55.11M
Normalized Net Operating Profit after Tax (NOPAT)	-66	-28	-21	-21	-31	15	-11	-24	-24	-37	-48
Normalized NOPAT Margin	0.00%	0.00%	-119.03%	-144.68%	-209.96%	23.03%	-28.19%	-89.45%	-90.40%	-243.72%	-593.29%
Pre Tax Income Margin	0.00%	0.00%	-150.82%	-168.76%	-263.03%	32.41%	-18.34%	-98.09%	-98.52%	-298.55%	-766.02%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Arcellx's Financials

When does Arcellx's financial year end?

According to the most recent income statement we have on file, Arcellx's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Arcellx's net income changed over the last 3 years?

The last 5 years of Arcellx's net income performance:

2021: -$64.97 million
2022: -$188.68 million
2023: -$70.69 million
2024: -$107.35 million

Find out what analysts predict for Arcellx in the coming months.

What is Arcellx's operating income?

Arcellx's total operating income in 2024 was -$137.57 million, based on the following breakdown:

Total Gross Profit: $107.94 million
Total Operating Expenses: $245.51 million

How has Arcellx revenue changed over the last 3 years?

Over the last 3 years, Arcellx's total revenue changed from $0.00 in 2021 to $107.94 million in 2024, a change of 10,793,600,000.0%.

How much debt does Arcellx have?

Arcellx's total liabilities were at $256.54 million at the end of 2024, a 24.5% decrease from 2023, and a 1,416.3% increase since 2021.

How much cash does Arcellx have?

In the past 3 years, Arcellx's cash and equivalents has ranged from $30.83 million in 2021 to $394.58 million in 2023, and is currently $105.68 million as of their latest financial filing in 2024.

How has Arcellx's book value per share changed over the last 3 years?

Over the last 3 years, Arcellx's book value per share changed from -272.22 in 2021 to 8.41 in 2024, a change of -103.1%.

Related Companies

This page (NASDAQ:ACLX) was last updated on 6/12/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Arcellx (ACLX) Financials

Frequently Asked Questions About Arcellx's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Arcellx (ACLX) Financials

Annual Income Statements for Arcellx

Quarterly Income Statements for Arcellx

Annual Cash Flow Statements for Arcellx

Quarterly Cash Flow Statements for Arcellx

Annual Balance Sheets for Arcellx

Quarterly Balance Sheets for Arcellx

Annual Metrics And Ratios for Arcellx

Quarterly Metrics And Ratios for Arcellx

Frequently Asked Questions About Arcellx's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools